Skip to search.
 All Ordinaries Up0.10%

More On NRT.AX

Quotes

Charts

News & Info

Company

Analyst Coverage

  • Analyst Opinion
  • Analyst Estimates

Ownership

Financials


Novogen Ltd (NRT.AX)

-ASX
0.17 Down 0.01(2.94%) 13:17
Add to Portfolio
ProfileGet Profile for:
Novogen Ltd
16 - 20 Edgeworth David Avenue
Level 1
Hornsby, NSW 2077
Australia - Map
Phone: 61 2 9476 0344
Fax: 61 2 9476 0388
Website: http://www.novogen.com

Details 
Index Membership:N/A
Sector:Healthcare
Industry:Drug Manufacturers - Major
Full Time Employees:N/A

Business Summary 

Novogen Limited operates as a pharmaceutical drug development company worldwide. It focuses on the development of a family of anti-cancer drugs based on super-benzopyran and stealth drug technologies. The company’s lead drug candidate is CS-6, a mitochondrial electron transfer inhibitor for the treatment of temozolomide-resistant glioblastoma multiforme and late-stage chemo-refractory ovarian cancer. Novogen Limited was founded in 1994 and is based in Hornsby, Australia.

Key Statistics


Company Websites 
Home Page
Search Yahoo!7 for:
More on Novogen Ltd

Key Executives 
 PayExercised
Prof. Graham Edmund Kelly BSC (Hons), BVSc (Hons), Ph.D., 69
Chairman and Chief Exec. Officer
N/AN/A
Mr. Steven Coffey B. Comm., CA,
Acting Chief Financial Officer, Non-Exec. Director, Chairman of Audit Committee and Member of Remuneration Committee
38.00kN/A
Dr. David Brown B.App. Sc. (Hons), Ph.D., GradDip,
Chief Scientific Officer
34.00kN/A
Dr. Andrew Heaton B.Sc (Hons) Ph.D.,
Vice-Pres of Drug Discovery, Manufacture & Patents
116.00kN/A
Mr. Lionel Mateo M. Law,
Company Sec.
N/AN/A
Amounts are as of 31/12/2013 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in AUD.
View Insiders